Introduction
hyperphosphatemia
END-STAGE RENAL DISEASE, HYPERPHOSPHATEMIA, COMPLICATION
Maintenance hemodialysis is a commonly used treatment for end-stage renal disease. In this condition, phosphate becomes easily retained in the body due to decreased renal function, leading to hyperphosphatemia, a common complication in these patients [Primary interventions for hyperphosphatemia management include the dietary restriction of phosphorus intake (DRPI) and the use of phosphate binders [There are a variety of strategies, including educational and behavioral interventions, to improve the phosphorus control of hemodialysis patients (HPs) by improving their adherence to treatment regimens and helping them engage in healthy behaviors [Considering the importance of empowering HPs with hyperphosphatemia and their FCGs in relation to adherence to dietary and medication regimens for the purpose of controlling serum phosphorus levels, this study investigated the effect of a family-centered empowerment program (FCEP) on hyperphosphatemia management and specifically the subjects’ knowledge of phosphate control, adherence to DRPI, adherence to medication, and serum phosphorus level.